Marathon Capital Management’s Stereotaxis STXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,250
Closed -$37.7K 160
2024
Q1
$37.7K Hold
12,250
0.01% 147
2023
Q4
$21.4K Hold
12,250
0.01% 151
2023
Q3
$19.4K Sell
12,250
-25,000
-67% -$40K ﹤0.01% 154
2023
Q2
$57K Hold
37,250
0.01% 151
2023
Q1
$76K Sell
37,250
-10,000
-21% -$22.5K 0.02% 157
2022
Q4
$104K Hold
47,250
0.03% 140
2022
Q3
$85K Hold
47,250
0.02% 147
2022
Q2
$87K Sell
47,250
-99,000
-68% -$237K 0.03% 139
2022
Q1
$546K Hold
146,250
0.16% 72
2021
Q4
$907K Sell
146,250
-2,000
-1% -$12K 0.21% 71
2021
Q3
$798K Buy
148,250
+1,000
+0.7% +$7.54K 0.18% 79
2021
Q2
$1.42M Sell
147,250
-1,450
-1% -$11.4K 0.33% 52
2021
Q1
$999K Buy
148,700
+10,500
+8% +$62.3K 0.26% 57
2020
Q4
$703K Sell
138,200
-8,250
-6% -$33.8K 0.21% 68
2020
Q3
$524K Buy
146,450
+33,700
+30% +$130K 0.19% 74
2020
Q2
$503K Buy
112,750
+3,250
+3% +$13.2K 0.19% 64
2020
Q1
$330K Buy
+109,500
New +$452K 0.15% 78

Other funds holding STXS

Marathon Capital Management's STXS Position: Q2 2024 in Review

Marathon Capital Management sold out of Stereotaxis (STXS) in Q2 2024, closing a stake of 12,250 shares — an estimated $37.7K sold.

Marathon Capital Management first reported a position in STXS in Q1 2020 and held it in 17 quarters. The position peaked at $1.42M in Q2 2021. 73 funds tracked by Wall St. Rank hold STXS as of Q2 2024.

  • Marathon Capital Management reported no remaining Stereotaxis position as of Q2 2024 after selling out during the quarter.
  • Marathon Capital Management sold 12,250 Stereotaxis shares in Q2 2024, an estimated $37.7K.
  • Marathon Capital Management first reported a position in Stereotaxis in Q1 2020 and held it in 17 quarters.
  • Marathon Capital Management's Stereotaxis position peaked at $1.42M in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Stereotaxis as of Q2 2024.

Based on Marathon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.